← Back to Intel
Insider ActivityNAMS
Kooij Louise Frederika, Chief Accounting Officer at NewAmsterdam Pharma Co N.V., sold $2.3M of NAMS
Updated Jun 6, 2026
Kooij Louise Frederika
Chief Accounting Officer
NewAmsterdam Pharma Co N.V. ·
$NAMS
Transaction Details
| Insider | Kooij Louise Frederika |
|---|---|
| Title | Chief Accounting Officer |
| Company | NewAmsterdam Pharma Co N.V. |
| Ticker | NAMS |
| Transaction Type | Sale |
| Transaction Date | 2026-05-26 |
| Shares Traded | 65,000 |
| Price Per Share | $35.69 |
| Total Value | $2.3M |
| Filed Date | 2026-05-27 |
| Accession Number | 0001193125-26-241983 |
Ownership Context
| Shares Owned After Transaction | 24,353 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001193125-26-241983
Other Insider Trades — NAMS
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Kooij Louise Frederika | Chief Accounting Officer | traded | $600K | 2026-05-26 |
| Kooij Louise Frederika | Chief Accounting Officer | traded | $54K | 2026-05-26 |
Other Trades by Kooij Louise Frederika
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| NAMS | NewAmsterdam Pharma Co N.V. | traded | $600K | 2026-05-26 |
| NAMS | NewAmsterdam Pharma Co N.V. | traded | $54K | 2026-05-26 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for NAMS — NewAmsterdam Pharma Co N.V. →
Track NAMS insider activity in real time on The Wire →
Get alerts when Kooij Louise Frederika files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 06, 2026 at 07:03 UTC